These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17059819

  • 21. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
    Rajkumar R, Pandey DK, Mahesh R, Radha R.
    Eur J Pharmacol; 2009 Apr 17; 608(1-3):32-41. PubMed ID: 19269287
    [Abstract] [Full Text] [Related]

  • 22. Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.
    Kumar A, Garg R.
    Fundam Clin Pharmacol; 2009 Feb 17; 23(1):89-95. PubMed ID: 19207541
    [Abstract] [Full Text] [Related]

  • 23. Olfactory bulbectomy induces rapid and stable changes in basal and stress-induced locomotor activity, heart rate and body temperature responses in the home cage.
    Vinkers CH, Breuer ME, Westphal KG, Korte SM, Oosting RS, Olivier B, Groenink L.
    Neuroscience; 2009 Mar 03; 159(1):39-46. PubMed ID: 19136045
    [Abstract] [Full Text] [Related]

  • 24. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
    van Riezen H, Schnieden H, Wren AF.
    Br J Pharmacol; 1977 Aug 03; 60(4):521-8. PubMed ID: 907867
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A, Yamada M, Yamada M, Takahashi K, Yamaguchi K, Murasawa H, Nakatani A, Tatsumi Y, Hirose N, Kamei J.
    Brain Res; 2008 May 07; 1208():160-9. PubMed ID: 18381208
    [Abstract] [Full Text] [Related]

  • 27. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    Lloyd KG, Zivkovic B, Sanger D, Depoortere H, Bartholini G.
    J Pharmacol Exp Ther; 1987 Apr 07; 241(1):245-50. PubMed ID: 3033203
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Time course of alterations after olfactory bulbectomy in mice.
    Mucignat-Caretta C, Bondí M, Caretta A.
    Physiol Behav; 2006 Dec 30; 89(5):637-43. PubMed ID: 16973183
    [Abstract] [Full Text] [Related]

  • 30. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.
    Bansal Y, Singh R, Saroj P, Sodhi RK, Kuhad A.
    Toxicol Appl Pharmacol; 2018 Sep 15; 355():257-268. PubMed ID: 30017640
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The olfactory bulbectomized rat as a model of depression.
    Leonard BE.
    Pol J Pharmacol Pharm; 1984 Sep 15; 36(5):561-9. PubMed ID: 6099892
    [Abstract] [Full Text] [Related]

  • 33. Olfactory bulbectomy in mice induces alterations in exploratory behavior.
    Zueger M, Urani A, Chourbaji S, Zacher C, Roche M, Harkin A, Gass P.
    Neurosci Lett; 2005 Feb 10; 374(2):142-6. PubMed ID: 15644281
    [Abstract] [Full Text] [Related]

  • 34. Effects of chronic activity wheel running and imipramine on masculine copulatory behavior after olfactory bulbectomy.
    Chambliss HO, Van Hoomissen JD, Holmes PV, Bunnell BN, Dishman RK.
    Physiol Behav; 2004 Sep 30; 82(4):593-600. PubMed ID: 15327906
    [Abstract] [Full Text] [Related]

  • 35. The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice.
    Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K.
    Neuroscience; 2008 Feb 06; 151(3):671-9. PubMed ID: 18164824
    [Abstract] [Full Text] [Related]

  • 36. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
    Connor TJ, Harkin A, Kelly JP, Leonard BE.
    Neuroimmunomodulation; 2000 Feb 06; 7(1):27-35. PubMed ID: 10601816
    [Abstract] [Full Text] [Related]

  • 37. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R, Radhakrishnan M, Borah M.
    Behav Pharmacol; 2008 Feb 06; 19(1):29-40. PubMed ID: 18195592
    [Abstract] [Full Text] [Related]

  • 38. A novel method for olfactory bulbectomy using photochemically induced lesion.
    Kang HM, Jin J, Lee S, Ryu J, Park C.
    Neuroreport; 2010 Feb 17; 21(3):179-84. PubMed ID: 20042896
    [Abstract] [Full Text] [Related]

  • 39. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
    Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, Hen R, Belzung C.
    Biol Psychiatry; 2008 Aug 15; 64(4):293-301. PubMed ID: 18406399
    [Abstract] [Full Text] [Related]

  • 40. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
    Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A.
    J Neurochem; 2009 Mar 15; 108(6):1423-33. PubMed ID: 19183263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.